Neuca buys stake in Bioscience

Neuca's subsidiary, Neuca Med, has acquired a 64.3 percent stake in Bioscience, a clinical research company. The transaction will strengthen the group's competences in the field of clinical research and will contribute to the development of the whole Neuca's health care segment," a statement read. The agreement stipulates that Neuca Med may increase its stake to 70 percent. Bioscience deals mostly in conducting phases I-IV of clinical research on new drugs and medical devices, as commissioned by pharmaceutical, biotechnological and research-oriented companies, and academic clients. Neuca is a Polish healthcare service provider with 25 years of experience in the industry.